{"id":7193,"date":"2025-12-24T16:10:56","date_gmt":"2025-12-24T15:10:56","guid":{"rendered":"https:\/\/synthelis.com\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/"},"modified":"2025-12-24T16:17:09","modified_gmt":"2025-12-24T15:17:09","slug":"synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology","status":"publish","type":"post","link":"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/","title":{"rendered":"Synthelis Biotech selected by France 2030 to industrialize its cell-free technology"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; custom_margin=&#8221;0px||||false|false&#8221; custom_padding=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;PT Serif||||||||&#8221; text_text_color=&#8221;#000000&#8243; text_font_size=&#8221;17px&#8221; text_line_height=&#8221;1.8em&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243; custom_padding=&#8221;3px|||||&#8221;]<\/p>\n<p data-start=\"238\" data-end=\"631\">Synthelis Biotech has been selected under the <span style=\"color: #4d1749;\"><strong><em data-start=\"284\" data-end=\"333\">\u201cInnovations in Biotherapies and Bioproduction\u201d<\/em> <\/strong><\/span>call for projects of the France 2030 program, operated by Bpifrance. This support will enable the development of <span style=\"color: #4d1749;\"><strong data-start=\"447\" data-end=\"463\">Cell-Free\u2019Up<\/strong><\/span>, a strategic project aimed at optimizing and industrializing our acellular bioproduction (cell-free) technology for the production of therapeutic and vaccine proteins.<\/p>\n<p data-start=\"633\" data-end=\"812\">The objective is to deliver a <span style=\"color: #4d1749;\"><strong>robust, reproducible, and GMP-compatible process<\/strong><\/span> capable of producing complex proteins <span style=\"color: #4d1749;\"><strong>at large scale<\/strong><\/span>, faster than traditional bioproduction systems.<\/p>\n<p data-start=\"814\" data-end=\"1088\">To support this scale-up, Synthelis Biotech is partnering with <span style=\"color: #4d1749;\"><strong data-start=\"877\" data-end=\"885\">TIBH<\/strong><\/span>, an industrial integrator recognized for its expertise in bioprocess development and scale-up. This complementary French consortium will accelerate access to a new generation of bioproduction solutions.<\/p>\n<p data-start=\"1090\" data-end=\"1297\">With <span style=\"color: #4d1749;\"><strong data-start=\"1095\" data-end=\"1111\">Cell-Free\u2019Up<\/strong><\/span>, Synthelis Biotech reaffirms its mission: <span style=\"color: #4d1749;\"><strong>accelerating biology to enable the production of proteins that are difficult to obtain, at a pace aligned with the needs of modern biomedicine.<\/strong><\/span><\/p>\n<p data-start=\"1299\" data-end=\"1318\"><span style=\"color: #4d1749;\"><strong>Biology at speed.<\/strong><\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Synthelis Biotech has been selected under the \u201cInnovations in Biotherapies and Bioproduction\u201d call for projects of the France 2030 program, operated by Bpifrance. This support will enable the development of Cell-Free\u2019Up, a strategic project aimed at optimizing and industrializing our acellular bioproduction (cell-free) technology for the production of therapeutic and vaccine proteins. The objective is [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":7185,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_surecart_dashboard_logo_width":"180px","_surecart_dashboard_show_logo":true,"_surecart_dashboard_navigation_orders":true,"_surecart_dashboard_navigation_invoices":true,"_surecart_dashboard_navigation_subscriptions":true,"_surecart_dashboard_navigation_downloads":true,"_surecart_dashboard_navigation_billing":true,"_surecart_dashboard_navigation_account":true,"footnotes":""},"categories":[28,30],"tags":[],"post_folder":[],"class_list":["post-7193","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog-en","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Synthelis Biotech selected by France 2030 to industrialize its cell-free technology<\/title>\n<meta name=\"description\" content=\"Backed by France 2030, Synthelis Biotech accelerates the industrial scale-up of its cell-free technology for complex protein production.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Synthelis Biotech selected by France 2030 to industrialize its cell-free technology\" \/>\n<meta property=\"og:description\" content=\"Backed by France 2030, Synthelis Biotech accelerates the industrial scale-up of its cell-free technology for complex protein production.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/\" \/>\n<meta property=\"og:site_name\" content=\"Synthelis\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-24T15:10:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-24T15:17:09+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/synthelis.com\/wp-content\/uploads\/2025\/12\/cell-free-up.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Caroline LOUBIER\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Caroline LOUBIER\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/\"},\"author\":{\"name\":\"Caroline LOUBIER\",\"@id\":\"https:\/\/synthelis.com\/en\/#\/schema\/person\/7173130156a4ecdbb86dcef2a9df3949\"},\"headline\":\"Synthelis Biotech selected by France 2030 to industrialize its cell-free technology\",\"datePublished\":\"2025-12-24T15:10:56+00:00\",\"dateModified\":\"2025-12-24T15:17:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/\"},\"wordCount\":251,\"image\":{\"@id\":\"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/synthelis.com\/wp-content\/uploads\/2025\/12\/cell-free-up.png\",\"articleSection\":[\"Blog\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/\",\"url\":\"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/\",\"name\":\"Synthelis Biotech selected by France 2030 to industrialize its cell-free technology\",\"isPartOf\":{\"@id\":\"https:\/\/synthelis.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/synthelis.com\/wp-content\/uploads\/2025\/12\/cell-free-up.png\",\"datePublished\":\"2025-12-24T15:10:56+00:00\",\"dateModified\":\"2025-12-24T15:17:09+00:00\",\"author\":{\"@id\":\"https:\/\/synthelis.com\/en\/#\/schema\/person\/7173130156a4ecdbb86dcef2a9df3949\"},\"description\":\"Backed by France 2030, Synthelis Biotech accelerates the industrial scale-up of its cell-free technology for complex protein production.\",\"breadcrumb\":{\"@id\":\"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/#primaryimage\",\"url\":\"https:\/\/synthelis.com\/wp-content\/uploads\/2025\/12\/cell-free-up.png\",\"contentUrl\":\"https:\/\/synthelis.com\/wp-content\/uploads\/2025\/12\/cell-free-up.png\",\"width\":1080,\"height\":700,\"caption\":\"Cell-free scale-up\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/synthelis.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Synthelis Biotech selected by France 2030 to industrialize its cell-free technology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/synthelis.com\/en\/#website\",\"url\":\"https:\/\/synthelis.com\/en\/\",\"name\":\"Synthelis\",\"description\":\"Biology at speed\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/synthelis.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/synthelis.com\/en\/#\/schema\/person\/7173130156a4ecdbb86dcef2a9df3949\",\"name\":\"Caroline LOUBIER\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/874fe5bc2396cb7c1692f499dc8b5afb72caff7b52b8111acc3aa3ae4e65010f?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/874fe5bc2396cb7c1692f499dc8b5afb72caff7b52b8111acc3aa3ae4e65010f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/874fe5bc2396cb7c1692f499dc8b5afb72caff7b52b8111acc3aa3ae4e65010f?s=96&d=mm&r=g\",\"caption\":\"Caroline LOUBIER\"},\"url\":\"https:\/\/synthelis.com\/en\/author\/caroline\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Synthelis Biotech selected by France 2030 to industrialize its cell-free technology","description":"Backed by France 2030, Synthelis Biotech accelerates the industrial scale-up of its cell-free technology for complex protein production.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/","og_locale":"en_US","og_type":"article","og_title":"Synthelis Biotech selected by France 2030 to industrialize its cell-free technology","og_description":"Backed by France 2030, Synthelis Biotech accelerates the industrial scale-up of its cell-free technology for complex protein production.","og_url":"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/","og_site_name":"Synthelis","article_published_time":"2025-12-24T15:10:56+00:00","article_modified_time":"2025-12-24T15:17:09+00:00","og_image":[{"width":1080,"height":700,"url":"http:\/\/synthelis.com\/wp-content\/uploads\/2025\/12\/cell-free-up.png","type":"image\/png"}],"author":"Caroline LOUBIER","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Caroline LOUBIER","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/#article","isPartOf":{"@id":"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/"},"author":{"name":"Caroline LOUBIER","@id":"https:\/\/synthelis.com\/en\/#\/schema\/person\/7173130156a4ecdbb86dcef2a9df3949"},"headline":"Synthelis Biotech selected by France 2030 to industrialize its cell-free technology","datePublished":"2025-12-24T15:10:56+00:00","dateModified":"2025-12-24T15:17:09+00:00","mainEntityOfPage":{"@id":"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/"},"wordCount":251,"image":{"@id":"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/synthelis.com\/wp-content\/uploads\/2025\/12\/cell-free-up.png","articleSection":["Blog","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/","url":"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/","name":"Synthelis Biotech selected by France 2030 to industrialize its cell-free technology","isPartOf":{"@id":"https:\/\/synthelis.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/#primaryimage"},"image":{"@id":"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/synthelis.com\/wp-content\/uploads\/2025\/12\/cell-free-up.png","datePublished":"2025-12-24T15:10:56+00:00","dateModified":"2025-12-24T15:17:09+00:00","author":{"@id":"https:\/\/synthelis.com\/en\/#\/schema\/person\/7173130156a4ecdbb86dcef2a9df3949"},"description":"Backed by France 2030, Synthelis Biotech accelerates the industrial scale-up of its cell-free technology for complex protein production.","breadcrumb":{"@id":"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/#primaryimage","url":"https:\/\/synthelis.com\/wp-content\/uploads\/2025\/12\/cell-free-up.png","contentUrl":"https:\/\/synthelis.com\/wp-content\/uploads\/2025\/12\/cell-free-up.png","width":1080,"height":700,"caption":"Cell-free scale-up"},{"@type":"BreadcrumbList","@id":"https:\/\/synthelis.com\/en\/synthelis-biotech-selected-by-france-2030-to-industrialize-its-cell-free-technology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/synthelis.com\/en\/"},{"@type":"ListItem","position":2,"name":"Synthelis Biotech selected by France 2030 to industrialize its cell-free technology"}]},{"@type":"WebSite","@id":"https:\/\/synthelis.com\/en\/#website","url":"https:\/\/synthelis.com\/en\/","name":"Synthelis","description":"Biology at speed","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/synthelis.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/synthelis.com\/en\/#\/schema\/person\/7173130156a4ecdbb86dcef2a9df3949","name":"Caroline LOUBIER","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/874fe5bc2396cb7c1692f499dc8b5afb72caff7b52b8111acc3aa3ae4e65010f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/874fe5bc2396cb7c1692f499dc8b5afb72caff7b52b8111acc3aa3ae4e65010f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/874fe5bc2396cb7c1692f499dc8b5afb72caff7b52b8111acc3aa3ae4e65010f?s=96&d=mm&r=g","caption":"Caroline LOUBIER"},"url":"https:\/\/synthelis.com\/en\/author\/caroline\/"}]}},"_links":{"self":[{"href":"https:\/\/synthelis.com\/en\/wp-json\/wp\/v2\/posts\/7193","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/synthelis.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/synthelis.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/synthelis.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/synthelis.com\/en\/wp-json\/wp\/v2\/comments?post=7193"}],"version-history":[{"count":6,"href":"https:\/\/synthelis.com\/en\/wp-json\/wp\/v2\/posts\/7193\/revisions"}],"predecessor-version":[{"id":7200,"href":"https:\/\/synthelis.com\/en\/wp-json\/wp\/v2\/posts\/7193\/revisions\/7200"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/synthelis.com\/en\/wp-json\/wp\/v2\/media\/7185"}],"wp:attachment":[{"href":"https:\/\/synthelis.com\/en\/wp-json\/wp\/v2\/media?parent=7193"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/synthelis.com\/en\/wp-json\/wp\/v2\/categories?post=7193"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/synthelis.com\/en\/wp-json\/wp\/v2\/tags?post=7193"},{"taxonomy":"post_folder","embeddable":true,"href":"https:\/\/synthelis.com\/en\/wp-json\/wp\/v2\/post_folder?post=7193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}